Gastric Intestinal Metaplasia in an Underserved Population in the USA: Prevalence, Epidemiologic and Clinical Features

被引：13
作者：
Almouradi, Tarek [1 ]
Hiatt, Tadd [1 ]
Attar, Bashar [1 ]
机构：
[1] John H Stroger Hosp Cook Cty, Dept Med, Div Gastroenterol & Hepatol, Chicago, IL 60612 USA
来源：
GASTROENTEROLOGY RESEARCH AND PRACTICE | 2013年 / 2013卷
关键词：
HELICOBACTER-PYLORI ERADICATION; SEQUENTIAL THERAPY; CANCER; RISK;
D O I：
10.1155/2013/856256
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Gastric intestinal metaplasia is an important stage in the development of gastric cancer. Limited data is available regarding the prevalence of gastric intestinal metaplasia in the United States. We conducted a retrospective review of esophagogastroduodenoscopies performed in our endoscopy unit between the months of April and October 2010 to evaluate the prevalence and the epidemiologic and endoscopic features of gastric intestinal metaplasia in an underserved population in the United States.
引用
收藏
页数：4
相关论文
共 14 条
  • [1] CORREA P, 1992, CANCER RES, V52, P6735
  • [2] INTESTINAL METAPLASIA AND HELICOBACTER-PYLORI - AN ENDOSCOPIC BIOPTIC STUDY OF THE GASTRIC ANTRUM
    CRAANEN, ME
    DEKKER, W
    BLOK, P
    FERWERDA, J
    TYTGAT, GNJ
    [J]. GUT, 1992, 33 (01) : 16 - 20
  • [3] PREVALENCE OF INTESTINAL METAPLASIA IN HELICOBACTER-PYLORI GASTRITIS
    EIDT, S
    STOLTE, M
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1994, 29 (07) : 607 - 610
  • [4] FENNERTY MB, 1992, CANCER EPIDEM BIOMAR, V1, P293
  • [5] Prevalence of subtypes of intestinal metaplasia in the general population and in patients with autoimmune chronic atrophic gastritis
    Petersson, F
    Borch, K
    Franzén, LE
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2002, 37 (03) : 262 - 266
  • [6] Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial
    Romano, Marco
    Cuomo, Antonio
    Gravina, Antonietta G.
    Miranda, Agnese
    Iovene, Maria Rosaria
    Tiso, Angelo
    Sica, Mariano
    Rocco, Alba
    Salerno, Raffaele
    Marmo, Riccardo
    Federico, Alessandro
    Nardone, Gerardo
    [J]. GUT, 2010, 59 (11) : 1465 - 1470
  • [7] Helicobacter pylori eradication with either seven-day or 10-day triple therapies, and with a 10-day sequential regimen
    Scaccianoce, G
    Hassan, C
    Panarese, A
    Piglionica, D
    Morini, S
    Zullo, A
    [J]. CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 20 (02) : 113 - 117
  • [8] Twelve-month endoscopic and histological analysis following proton-pump inhibitor-based triple therapy in Helicobacter pylori-positive patients with gastric ulcers
    Tulassay, Zsolt
    Stolte, Manfred
    Engstrand, Lars
    Butruk, Eugeniusz
    Malfertheiner, Peter
    Dite, Petr
    Tchernev, Konstantin
    Wong, Benjamin C. Y.
    Gottlow, Mattis
    Eklund, Stefan
    Wrangstadh, Michael
    Herszenyi, Laszlo
    Nagy, Peter
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2010, 45 (09) : 1048 - 1058
  • [9] Helicobacter pylori infection and the development of gastric cancer.
    Uemura, N
    Okamoto, S
    Yamamoto, S
    Matsumura, N
    Yamaguchi, S
    Yamakido, M
    Taniyama, K
    Sasaki, N
    Schlemper, RJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (11) : 784 - 789
  • [10] Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication -: A randomized trial
    Vaira, Dino
    Zullo, Angelo
    Vakil, Nimish
    Gatta, Luigi
    Ricci, Chiara
    Perna, Federico
    Hassan, Cesare
    Bernabucci, Veronica
    Tampieri, Andrea
    Morini, Sergio
    [J]. ANNALS OF INTERNAL MEDICINE, 2007, 146 (08) : 556 - 145
12